News | April 30, 2015

SCAI Announces 2015 Late-Breaking Clinical Trials

Subjects range from orbital atherectomy to platelet function testing

April 30, 2015 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the following late-breaking clinical trials to be presented at its 2015 Scientific Sessions, May 6-9 in San Diego:

Thursday, May 7, 11:45 a.m. to 12:15 p.m. Pacific Time

Session Moderators: Ted A Bass, M.D., FSCAI, and Gregg W. Stone, M.D., FSCAI

  • Orbital Atherectomy Treatment of Severely Calcified Coronary Lesions:  Two-Year Results of the ORBIT II Trial and Long-Term Economic Analysis, presented by Jeffrey Chambers, M.D., FSCAI
  • Ticagrelor versus Clopidogrel in Troponin-negative Patients with Acute Coronary Syndrome Undergoing Ad Hoc Percutaneous Coronary Intervention: Results of a Prospective, Randomized, Multicenter Pharmacodynamic Study, presented by Roxana Mehran, M.D., FSCAI
  • Impact of Combined Lipid Lowering with Calcium Channel Antagonist-based Blood Pressure Control on Coronary Plaque Regression: MILLION Study, presented by Masa-aki Kawashiri, M.D.

 

Friday, May 8, 9:00 a.m. to 9:30 a.m. Pacific Time

Session Moderators: Matthew Price, M.D., FSCAI, and Roxana Mehran, M.D., FSCAI

  • OUTSIDE START Cilostazol Bridging Study: 8-Year Experience with Outpatient Cilostazol Bridging in High Stent Thrombosis Risk Paclitaxel Drug-Eluting Stents in Patients Having Surgery During the Proven At-Risk Period, presented by Charles L. Laham, M.D., FSCAI 
  • 90 Day Effectiveness and Safety of Prasugrel vs. Clopidogrel as Used in Clinical Practice in Patients With ACS Undergoing PCI: Initial Findings from the PROMETHEUS Study, presented by Usman Baber, M.D.
  • Impact of an Integrated Treatment Algorithm Based on Platelet Function Testing and Clinical Risk Assessment: Results of the TRIAGE study, presented by George D. Dangas, M.D., Ph.D., FSCAI.

 

For more information: www.scai.org

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init